Skip to main content
. 2024 Jul 18;16:94. doi: 10.1186/s13148-024-01707-w

Fig. 1.

Fig. 1

Schematic representation of the three assumptions and study design. IVs Instrumental variables. SNPs Single nucleotide polymorphisms. Assumption 1: The selected genetic IVs are robustly associated with the exposure. Assumption 2: The chosen IVs are not associated with potential confounders. Assumption 3: The IVs can only influence the risk of the outcome dependently through exposure